Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Cardiogenesis Corporation announces that it sponsored an educational symposium in conjunction at TCT meeting

Cardiogenesis Corporation, a market leader in laser transmyocardial revascularization (TMR), announced that it sponsored an educational symposium yesterday in conjunction with the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.

The symposium, titled "Opportunities in Refractory Angina" was attended by over 80 cardiologists.  The Program Chairman was Christopher J. White MD, Chairman, Department of Cardiovascular Disease Ochsner Clinic, and the faculty included Timothy D. Henry MD Director of Research Minneapolis Heart Institute, Marvin J. Slepian MD, Clinical Professor of Medicine University of Arizona and Michael J. Bates, Cardiothoracic Surgeon Ochsner Clinic.

"The challenge of effectively treating patients with refractory angina is that these patients may be followed by any one of thousands of cardiologists, internists, general practitioners, and at times heart failure specialists. The TCT program was designed to update the cardiology community on clinical options and in the case of Dr. Henry's presentation, effective strategies for cardiologists to build a refractory angina practice" stated Paul J. McCormick Executive Chairman Cardiogenesis.  He continued "we believe we have a solid opportunity for our current technology by working with the cardiology community to develop patient referrals.  Considering the early clinical results achieved, we believe that opportunity can significantly increase with the addition of various biologics.  We have a meeting scheduled with the FDA on October 21 in Rockville, MD to discuss our IDE submission for our PHOENIX Combination Delivery System."

About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia.  The company's market leading FDA approved Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina.  Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease.

Source: Reuters

You can discuss more about Cardiology and related topics in our Cardiology Group.